Giammanco, Antonina
 Distribuzione geografica
Continente #
NA - Nord America 2.292
EU - Europa 859
AS - Asia 465
SA - Sud America 115
AF - Africa 18
OC - Oceania 4
Totale 3.753
Nazione #
US - Stati Uniti d'America 2.280
IT - Italia 393
SG - Singapore 225
CN - Cina 131
DE - Germania 122
BR - Brasile 103
FI - Finlandia 71
GB - Regno Unito 51
IE - Irlanda 43
RU - Federazione Russa 22
BE - Belgio 21
AT - Austria 20
RO - Romania 18
NL - Olanda 16
FR - Francia 15
IN - India 14
TR - Turchia 14
SE - Svezia 13
UA - Ucraina 13
HK - Hong Kong 12
IQ - Iraq 10
IR - Iran 9
GR - Grecia 8
CA - Canada 7
KR - Corea 7
PT - Portogallo 6
ES - Italia 5
IL - Israele 5
AR - Argentina 4
JP - Giappone 4
MY - Malesia 4
TW - Taiwan 4
AU - Australia 3
CH - Svizzera 3
CI - Costa d'Avorio 3
CY - Cipro 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ID - Indonesia 3
MA - Marocco 3
PL - Polonia 3
SA - Arabia Saudita 3
CL - Cile 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
MM - Myanmar 2
MX - Messico 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BH - Bahrain 1
DK - Danimarca 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
TG - Togo 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 3.753
Città #
Chandler 322
Fairfield 268
Ashburn 228
Singapore 165
Houston 156
Seattle 143
Woodbridge 131
Wilmington 101
Cambridge 99
Palermo 76
New York 68
Medford 64
Ann Arbor 58
Altamura 54
Des Moines 41
Dublin 41
Princeton 40
Lawrence 37
Santa Clara 27
San Diego 25
London 23
Nanjing 22
Brussels 20
Rome 19
Ludwigshafen am Rhein 18
Beijing 17
Bremen 17
Helsinki 17
Milan 17
Venice 16
Los Angeles 13
Boardman 11
Council Bluffs 11
Jinan 10
Shenyang 10
Falkenstein 9
Hebei 9
Lappeenranta 9
Naples 9
Dearborn 8
Hong Kong 8
Nanchang 8
Changsha 7
Izmir 7
Munich 7
Vienna 7
Belo Horizonte 6
Favara 6
Nuremberg 6
Tehran 6
Tianjin 6
Baghdad 5
Cagliari 5
Guangzhou 5
Guarulhos 5
Ningbo 5
Pune 5
Tel Aviv 5
Bologna 4
Frankfurt am Main 4
Hanover 4
Moscow 4
Paris 4
San Paolo di Civitate 4
Seongnam 4
São Paulo 4
Trivento 4
Tulsa 4
Washington 4
Abidjan 3
Amsterdam 3
Battipaglia 3
Cedar Knolls 3
Central 3
Jacksonville 3
Kumar 3
New Taipei City 3
Norwalk 3
Orange 3
Porto 3
Redwood City 3
Rio de Janeiro 3
Saint Petersburg 3
Toronto 3
Turin 3
Zhengzhou 3
Alcamo 2
Athens 2
Atlanta 2
Bari 2
Brasília 2
Bratislava 2
Budapest 2
Burago di Molgora 2
Cairo 2
Caivano 2
Cardito 2
Casablanca 2
Chester 2
Chicago 2
Totale 2.661
Nome #
Resting energy expenditure and substrate oxidation in malnourished patients with type 1 glycogenosis 207
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 202
Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population 172
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 172
REDUCTION OF CHOLESTEROL WITH NUTRACEUTICAL: RESULTS OF A DOUBLE BLIND STUDY 166
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 151
Albumin versus solvent/detergent-treated pooled plasma as replacement fluid for long-term plasma exchange therapy in a patient with primary hypertriglyceridemia and recurrent hyperlipidemic pancreatitis 146
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing 142
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily 140
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 131
Liver and statins: a critical appraisal of the evidence 118
Is echocardiography mandatory for patients with chronic kidney disease? 116
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 115
Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia 113
The pathophysiology of intestinal lipoprotein production 98
Anti-PCSK9 treatment: Is ultra-low LDL always good? 96
Heterogenous forms of dyslipidemiain women with polycystic ovary syndrome 91
Therapeutic options for homozygous familial hypercholesterolemia: the role of Lomitapide 88
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 79
PULMONARY EMBOLISM IN AN EMERGENCY CARE UNIT: EVALUATION OF PREDICTIVE FACTORS FROM CLINICAL HISTORY AND PHYSICAL EXAM 75
Comparison of two polygenic risk score to identify non-monogenic primary hypocholesterolemias in a large cohort of Italian hypocholesterolemic subjects: Polygenic hypocholesterolemias 74
FISIOPATOLOGIA DELLA SINTESI DELLE LIPOPROTEINE INTESTINALI 71
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography 68
Valutazione in vivo dello stress ossidativo e dell'attivazione piastrinica nell'ipobetalipoproteinemia familiare: confronto con l'ipercolesterolemia familiare e l'iperalfalipoproteinemia familiare 67
Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases 67
EFFICACY AND SAFETY OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THE PAN-EUROPEAN RETROSPECTIVE OBSERVATIONAL STUDY 66
DeepSRE: Identification of sterol responsive elements and nuclear transcription factors Y proximity in human DNA by Convolutional Neural Network analysis 65
Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients 64
Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial 63
PREVALENCE OF STATIN INTOLERANCE IN A COHORT OF OUTPATIENTS IN A LIPID CLINIC 59
PCSK9-D374Y MEDIATED LDL-R DEGRADATION CAN BE FUNCTIONALLY INHIBITED BY EGF-A AND TRUNCATED EGF-A PEPTIDES. AN IN VITRO STUDY 53
EFFECTIVENESS AND SAFETY OF LOMITAPIDE IN A PATIENT WITH FAMILIAL CHYLOMICRONEMIA SYNDROME 51
An unusual case of chronic diarrhea: a case report 48
MUTATION IN CANDIDATE GENES ACCOUNT FOR A SMALL MINORITY OF HYPOBETALIPOPROTEINEMIAS AND NGS ANALYSIS SUPPORT POLYGENICITY IN MUTATION-NEGATIVE PATIENTS 48
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 47
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism 44
Lack of phenotypic additive effect of familial defective apolipoprotein B3531 in familial hypercholesterolaemia 41
IDENTIFICATION OF P.LEU167DEL APOE GENE MUTATION BY NEXT GENERATION SEQUENCING IN A LARGE HYPERCHOLESTEROLEMIC FAMILY 40
MOLECULAR CHARACTERIZATION OF PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE WITH "EXTREME LDL-C PHENOTYPES" 40
Derivation and validation of a predictive mortality model of in-hospital patients with Acinetobacter baumannii nosocomial infection or colonization 39
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 38
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 34
Intestinal epithelial HuR modulates distinct pathways of proliferation and apoptosis and attenuates small intestinal and colonic tumor development. 34
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome 34
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 33
Statin-induced autoimmune myositis: a proposal of an "experience-based" diagnostic algorithm from the analysis of 69 patients 32
Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study 26
Do genetically determined very high and very low LDL levels contribute to Lp(a) plasma concentration? 26
Resistive index of ophthalmic artery as an imaging biomarker of hypertension-related vascular and kidney damage 26
THE ROLE OF TRANSIENT ELASTOGRAPHY IN NAFLD 24
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 24
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 23
Erdheim-Chester disease as complex clinical presentation and diagnosis: A case report and concise review of literature 16
Resistive index of ophthalmic artery as an imaging biomarker of hypertension-related vascular and kidneydamage 13
Six genetic variants are associated with cardiovascular disease independently from canonical risk factors: a new method to refine GWAS results based on the UKBiobank phenotype database 10
null 4
Resistive index of ophthalmic artery as an imaging biomarker of hypertension-related vascular and kidney damage 1
Totale 4.131
Categoria #
all - tutte 21.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.978


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020146 0 0 0 0 0 0 0 0 0 35 92 19
2020/2021408 19 31 47 32 23 42 28 27 33 61 37 28
2021/2022506 13 48 35 6 6 17 20 31 59 111 44 116
2022/2023903 74 174 31 116 67 138 37 79 110 10 33 34
2023/2024494 18 64 46 59 23 127 39 29 9 20 16 44
2024/2025708 19 90 55 68 40 48 84 87 82 135 0 0
Totale 4.131